Aerocrine AB

(ACNOF)

By |

Profile

Aerocrine AB is a medical technology company focused on improving the treatment of patients with inflamed airways. The company offers exhaled nitric oxide (NO) monitoring devices for research and clinical applications. Aerocrine's devices utilize methods for measuring minute concentrations of NO, and incorporate NO scrubbers to eliminate atmospheric NO from the patient's breath. Measuring NO values helps doctors differentiate asthma from similar conditions, and differentiate various forms of asthma from other airway diseases. The company markets two products globally namely NIOX Flex and NIOX MINO. These products are widely used by primary care asthma specialists in Europe, and have recently gained US regulatory approval. Distribution agreements have also been signed in Japan, and regulatory approval has been secured in China. The company has offices and subsidiaries in Sweden, Germany, the United States, and the United Kingdom.

Contact Information

Website: www.aerocrine.com
Email: investor.relations@aerocrine.com
Main Phone: +46 86290780
Address: Råsundavägen 18
Address 2: P.O. Box 1024
City / Town: Solna
Country: SE
Postal Code: 171 71

Issuer Information

Exchange: GREY
Employees: 107
NAICS: Electromedical and Electrotherapeutic Apparatus Manufacturing(334510)

Equities News

Profile

Aerocrine AB is a medical technology company focused on improving the treatment of patients with inflamed airways. The company offers exhaled nitric oxide (NO) monitoring devices for research and clinical applications. Aerocrine's devices utilize methods for measuring minute concentrations of NO, and incorporate NO scrubbers to eliminate atmospheric NO from the patient's breath. Measuring NO values helps doctors differentiate asthma from similar conditions, and differentiate various forms of asthma from other airway diseases. The company markets two products globally namely NIOX Flex and NIOX MINO. These products are widely used by primary care asthma specialists in Europe, and have recently gained US regulatory approval. Distribution agreements have also been signed in Japan, and regulatory approval has been secured in China. The company has offices and subsidiaries in Sweden, Germany, the United States, and the United Kingdom.

Contact Information

Website: www.aerocrine.com
Email: investor.relations@aerocrine.com
Main Phone: +46 86290780
Address: Råsundavägen 18
Address 2: P.O. Box 1024
City / Town: Solna
Country: SE
Postal Code: 171 71

Issuer Information

Exchange: GREY
Employees: 107
NAICS: Electromedical and Electrotherapeutic Apparatus Manufacturing(334510)

Equities News

$ 0.27 $ 0. (0.00%)
Last Price 0.27 Change $ 0. Change % 0.00 Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open N/A High N/A Low N/A Prev Close 0.27
Last Trade Volume 0 52 Wk Hi N/A 52 Wk Low N/A
Market Cap 185.2 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 698,844,749.00 EPS (TTM) -0.09 PE Ratio N/A Exchange Greys